Combined with the results of co-occurrence and burst keywords analysis, we found that the focused hotspot was the molecular functions of LKB1, and the emerging hotspots are the clinical studies about LKB1 and co-mutated genes as biomarkers in tumors, especially in lung adenocarcinoma. This evidence concerns the gene STK11 and lung adenocarcinoma.